World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
33809
World Ranking
14434
National Ranking
180

Overview

Bertrand Tombal is affiliated with the Université Catholique de Louvain in Belgium. Their research primarily spans the field of Medicine, with a significant focus on subfields such as Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, and Endocrinology, Diabetes and Metabolism.

Their scholarly output includes contributions to several main topics of study including Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, Hormonal and reproductive studies, Cancer Treatment and Pharmacology, and Bone health and treatments.

Among their notable recent papers are:

  • Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation (2020, The Lancet Oncology)
  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020, Annals of Oncology)
  • Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2×2 factorial design (2022, The Lancet)
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020, New England Journal of Medicine)
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020, European Urology)

Frequent coauthors in their work include:

  • Fred Saad
  • Karim Fizazi
  • Neal D. Shore
  • Cora N. Sternberg
  • Maha Hussain

Tombal's publications are frequently found in the following venues:

  • Journal of Clinical Oncology
  • European Urology
  • Annals of Oncology
  • European Urology Oncology
  • The Journal of Urology

Best Publications

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hein van Poppel;Bertrand Tombal;Kris Vekemans

  • Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

    Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz

  • Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

    Matthias Guckenberger;Yolande Lievens;Angelique B Bouma;Laurence Collette

  • Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

    Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.: Annals of oncology : official journal of the European Society for Medical Oncology

    C. Parker;E. Castro;K. Fizazi;A. Heidenreich

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Prevention and early detection of prostate cancer

    Jack Cuzick;Mangesh A Thorat;Gerald L Andriole;Otis W Brawley;Otis W Brawley

  • Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

    Ronald de Wit;Johann de Bono;Cora N Sternberg;Karim Fizazi

  • Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

    Claire L. Vale;Sarah Burdett;Larysa H. M. Rydzewska;Laurence Albiges

  • Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The surtime randomized clinical trial

    Axel Bex;Peter Mulders;Michael A.S. Jewett;John Wagstaff

  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

    Tomasz M. Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    Wanling Xie;Meredith M. Regan;Marc Buyse;Susan Halabi

  • Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Peter C. Albertsen;Laurence Klotz;Bertrand Tombal;James Grady

  • Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

    Frédéric E. Lecouvet;Jawad El Mouedden;Laurence Collette;Emmanuel Coche

  • Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

    Ian I.F. Tannock;Karim Fizazi;Sergey S. Ivanov;Camilla Thellenberg C.T. Karlsson

  • Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Matthew Smith;Chris Parker;Fred Saad;Kurt Miller

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

    Neal D. Shore;Fred Saad;Michael S. Cookson;Daniel J. George

Frequent Co-Authors

Steven Joniau
Steven Joniau KU Leuven
Cora N. Sternberg
Cora N. Sternberg Cornell University
Fred Saad
Fred Saad University of Montreal
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
Celestia S. Higano
Celestia S. Higano University of Washington
Kurt Miller
Kurt Miller Charité - University Medicine Berlin
Matthew R. Smith
Matthew R. Smith Harvard University
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers diverse career opportunities, many of which extend beyond the traditional MD path. Increasingly, students and professionals seek online programs for flexibility and affordability.

For those interested in healthcare leadership, consider exploring affordable online mha programs. A Master’s in Healthcare Administration can support advancement to management roles within hospitals or clinics.

If you’re already a nurse aiming for top clinical positions, the cheapest dnp options online allow you to earn a Doctor of Nursing Practice and expand your career potential without disrupting your current job.

A pharmacy degree online is also available for those drawn to pharmaceutical sciences, opening doors in research, clinical practice, or industry roles.

Additionally, those interested in the vital field of medical data management may look into rhia certification programs online to work as registered health information administrators.

Best Scientists Citing Bertrand Tombal

Trending Scientists

Recently Published Articles